Fractyl Health (GUTS) Shares Outstanding (Weighted Average) (2023 - 2026)

Fractyl Health (GUTS) reported Shares Outstanding (Weighted Average) of $21.1 million for Q1 2026, down 56.72% year-on-year from $48.9 million in Q1 2025, and down 72.11% quarter-over-quarter from $75.8 million in Q4 2025.

Fractyl Health (GUTS) has 4 years of Shares Outstanding (Weighted Average) data on file, last reported at $21.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 56.72% year-over-year to $21.1 million; the trailing twelve-month figure through Mar 2026 stood at $21.1 million (down 56.72% YoY), and the FY2025 full-year result was $75.8 million, up 74.13% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $21.1 million, down from $75.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $75.8 million in Q4 2025 and bottomed at $2.1 million in Q1 2023.
  • A 4-year average of $33.1 million and a median of $41.9 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
  • Across the five-year window, Shares Outstanding (Weighted Average) soared 2218.19% in 2024 and sank 56.72% in 2026, its largest moves.
  • Tracing GUTS's Shares Outstanding (Weighted Average) over 4 years: stood at $2.1 million in 2023, then jumped by 1992.01% to $43.5 million in 2024, then surged by 74.13% to $75.8 million in 2025, then plunged by 72.11% to $21.1 million in 2026.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $21.1 million, $75.8 million, and $64.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 177,333.76 Bn
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - 185,491.37 Bn
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 100.00 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 55.66 Bn
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 254.10 Mn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 104.00 Mn
8 Evaxion A 65.44 Bn 65.42 Bn - 16.04 Bn
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 132.89 Mn
10 Fractyl Health 19.24 Mn 19.24 Mn - 21.15 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 21.15 Mn
Dec 31, 2025 75.82 Mn
Sep 30, 2025 64.65 Mn
Jun 30, 2025 48.95 Mn
Mar 31, 2025 48.87 Mn
Dec 31, 2024 43.54 Mn
Sep 30, 2024 41.89 Mn
Jun 30, 2024 47.90 Mn
Mar 31, 2024 29.74 Mn
Dec 31, 2023 2.08 Mn
Sep 30, 2023 2.07 Mn
Jun 30, 2023 2.07 Mn
Mar 31, 2023 2.06 Mn